A Study of Abemaciclib (LY2835219) With and Without Food in Participants With Metastatic Breast Cancer

NCT03703466 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Abemaciclib

Sponsor

Eli Lilly and Company